日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nature's Secret Neuro-Regeneration Pathway in Axolotls, Polychaetes and Planarians for Human Therapeutic Target Pathways

墨西哥钝口螈、多毛类和涡虫体内隐藏的神经再生通路,可作为人类治疗靶点通路

Mansor, Nur Izzati; Balqis, Tengku Nabilatul; Lani, Mohd Nizam; Lye, Kwan Liang; Nor Muhammad, Nor Azlan; Ismail, Wan Iryani Wan; Abidin, Shahidee Zainal

Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients

病毒入侵基因增多和先天免疫力受损是癌症患者中 COVID-19 传染性和严重程度增加的原因

Jennifer Yin Yee Kwan #, Liang-Tzung Lin #, Rachel Bell #, Jeffrey P Bruce, Christopher Richardson, Trevor J Pugh, Fei-Fei Liu

Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

利用化学蛋白质组学方法进行天然药物靶点鉴定:探针合成、靶点筛选和蛋白质鉴定

Chen, Xiao; Wang, Yutong; Ma, Nan; Tian, Jing; Shao, Yurou; Zhu, Bo; Wong, Yin Kwan; Liang, Zhen; Zou, Chang; Wang, Jigang

DWI Lesion Patterns Predict Outcome in Stroke Patients with Thrombolysis

DWI病灶模式可预测溶栓治疗卒中患者的预后

Liu, Dezhi; Scalzo, Fabien; Starkman, Sidney; Rao, Neal M; Hinman, Jason D; Kim, Doojin; Ali, Latisha K; Saver, Jeffrey L; Noorian, Ali Reza; Ng, Kwan; Liang, Conrad; Sheth, Sunil A; Yoo, Bryan; Liu, Xinfeng; Liebeskind, David S

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

对接受硼替佐米为基础的诱导治疗方案(包括分期治疗、PAD 或 VTD)的、符合移植条件的中国多发性骨髓瘤患者进行治疗结果和预后因素分析。

Chim, Chor Sang; Lie, Albert Kwok Wai; Chan, Eric Yuk Tat; Liu, Herman Sung Yu; Lau, Ching Wa; Yip, Sze Fai; Sim, Joycelyn; Wan, Thomas Shek-Kong; Ma, Edmond Shiu-Kwan; Liang, Raymond; Tse, Eric; Kwong, Yok-Lam